BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 1:50:00 PM | Browse: 956 | Download: 692
Publication Name World Journal of Neurology
Manuscript ID 5832
Country Japan
Received
2013-09-28 14:44
Peer-Review Started
2013-09-29 08:52
To Make the First Decision
2013-11-19 12:51
Return for Revision
2013-11-19 13:32
Revised
2013-12-03 23:41
Second Decision
2014-04-09 16:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 16:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-13 23:18
Typeset the Manuscript
2014-05-05 19:27
Publish the Manuscript Online
2014-05-06 17:55
ISSN 2218-6212 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Neurosciences
Manuscript Type Editorial
Article Title Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy
Manuscript Source Invited Manuscript
All Author List Hiroshi Takahashi and Kotaro Shimoda
Funding Agency and Grant Number
Corresponding Author Hiroshi Takahashi, MD, PhD, Department of Neurology, National Hospital Organization, Tottori Medical Center, 876 Mitsu, Tottori 689-0203, Japan. hiroshi@tottori-iryo.hosp.go.jp
Key Words Primary coenzyme Q10 deficiency; Multiple system atrophy; Cerebellar ataxia; COQ2 gene; Statin; Coenzyme Q10 supplementation; Reduced coenzyme Q10
Core Tip Recently, multiple system atrophy (MSA), relatively common in adult-onset neurodegenerative diseases, was shown to be linked to mutations in the COQ2 gene, one of the genes involved in the Coenzyme Q10 (CoQ10) biosynthesis pathway. Neurologists so far have not paid much attention to CoQ10 because primary CoQ10 deficiency caused by mutations in the CoQ10 synthesizing genes is very rare. The most important message is that primary CoQ10 deficiency is treatable with exogenous CoQ10 and that oral CoQ10 supplementation might be also beneficial for patients with MSA.
Publish Date 2014-05-06 17:55
Citation Takahashi H, Shimoda K. Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy. World J Neurol 2014; 4(1): 1-6
URL http://www.wjgnet.com/2218-6212/full/v4/i1/1.htm
DOI http://dx.doi.org/10.5316/wjn.v4.i1.1
Full Article (PDF) WJN-4-1.pdf
Full Article (Word) WJN-4-1.doc
Manuscript File 5832-Review.docx
Answering Reviewers 5832-Answering reviewers.pdf
Copyright License Agreement 5832-Copyright assignment.pdf
Peer-review Report 5832-Peer review(s).pdf
Scientific Editor Work List 5832-Scientific editor work list.doc